Skip to main content

Volume 19 - Issue 7 - July, 2007

Clinical Images
08/01/2008
Rajesh Jindal, MD; Rupesh George, MD; Balbir Singh, MD
Introduction of drug-eluting stent (DES) has led to a marked reduction in the problem of in-stent restenosis across all patient subsets and lesions complexities.7 Recently, several case reports of aneurysm formation after DES implantation...
Introduction of drug-eluting stent (DES) has led to a marked reduction in the problem of in-stent restenosis across all patient subsets and lesions complexities.7 Recently, several case reports of aneurysm formation after DES implantation...
Introduction of drug-eluting...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Vineeta Ahooja, MD; Deepak Thatai, MD
Variant angina is a distinct clinical entity first described by Prinzmetal and associates in 1959.1 The classic presentation is characterized by chest pain occurring at rest, and is more frequent in young women. Unlike true angina, the chest...
Variant angina is a distinct clinical entity first described by Prinzmetal and associates in 1959.1 The classic presentation is characterized by chest pain occurring at rest, and is more frequent in young women. Unlike true angina, the chest...
Variant angina is a distinct...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Henry E. Kim, MD, MPH
Rupture of atherosclerotic plaque leading to exposure of highly thrombogenic material to the blood pool with subsequent thrombus formation is the principal mechanism associated with acute coronary syndromes.1,2 Percutaneous coronary...
Rupture of atherosclerotic plaque leading to exposure of highly thrombogenic material to the blood pool with subsequent thrombus formation is the principal mechanism associated with acute coronary syndromes.1,2 Percutaneous coronary...
Rupture of atherosclerotic...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Matthew W. Martinez, MD, FACC; Martina Mookadam, MD; Farouk Mookadam, MB, BCh, MBBCh, MD, FRCPC, FACC
Hemolytic anemia related to intracardiac prosthetic materials is well recognized. It was first reported by Sayed et al, when a Teflon ASD patch produced intravascular hemolysis.1 Since then, intravascular hemolysis has been described after...
Hemolytic anemia related to intracardiac prosthetic materials is well recognized. It was first reported by Sayed et al, when a Teflon ASD patch produced intravascular hemolysis.1 Since then, intravascular hemolysis has been described after...
Hemolytic anemia related to...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Massoud A. Leesar, MD, FACC; Ziad Elghoul, MD
Coronary artery fistulae are uncommon vascular anomalies. The incidence of these anomalies is low, ranging from 0.2 to 0.25%.1 The fistulae frequently drain into one of the ventricles, the pulmonary arteries, the coronary sinus and the...
Coronary artery fistulae are uncommon vascular anomalies. The incidence of these anomalies is low, ranging from 0.2 to 0.25%.1 The fistulae frequently drain into one of the ventricles, the pulmonary arteries, the coronary sinus and the...
Coronary artery fistulae are...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Oliver J. Ormerod, FRCP, DM; Ryan G. Schrale, MBBS; Keith M. Channon, MD, PhD, FRCP
Case Report. A 42-year-old asymptomatic female with longstanding Type-1 diabetes and secondary chronic renal failure underwent evaluation for potential kidney-pancreas transplantation. A screening treadmill myocardial perfusion scintigraphy...
Case Report. A 42-year-old asymptomatic female with longstanding Type-1 diabetes and secondary chronic renal failure underwent evaluation for potential kidney-pancreas transplantation. A screening treadmill myocardial perfusion scintigraphy...
Case Report. A 42-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Sorin J. Brener, MD; Steven R. Steinhubl, MD; Eric J. Topol, MD; Danielle M. Brennan, MS; Peter B. Berger, MD
When clopidogrel is added to background aspirin therapy, it reduces the composite of cardiovascular death, myocardial infarction (MI) or stroke in patients with acute coronary syndromes (ACS)1 or percutaneous revascularization.2 The most...
When clopidogrel is added to background aspirin therapy, it reduces the composite of cardiovascular death, myocardial infarction (MI) or stroke in patients with acute coronary syndromes (ACS)1 or percutaneous revascularization.2 The most...
When clopidogrel is added to...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Babak Kazemi, MD; Naser Aslanabadi, MD; Bahram Sohrabi, MD
Acute aortic dissection during coronary arteriography or percutaneous coronary intervention is quite rare,1,2 but is a feared complication. Patients in this clinical setting may have a potential risk for acute myocardial infarction (MI)...
Acute aortic dissection during coronary arteriography or percutaneous coronary intervention is quite rare,1,2 but is a feared complication. Patients in this clinical setting may have a potential risk for acute myocardial infarction (MI)...
Acute aortic dissection during...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Jeffrey H. Freihage, MD; Michael Tempelhof, MD; Bruce E. Lewis, MD; Dinesh Arab, MD; Lowell H. Steen, MD; Ferdinand Leya, MD; Kevin P. Cohoon, MD; Dominique Joyal, MD; Robert S. Dieter, MD, RVT
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Mehnaz Atiq, MD; Nadeem Aslam, MD; Khawar Abbass Kazmi, MD, FCPS
Patent ductus arteriosus (PDA) can cause congestive cardiac failure, repeated pneumonia, pulmonary hypertension and an increased risk for endocarditis. Transcatheter closure of PDA is currently the preferred therapeutic alternative to...
Patent ductus arteriosus (PDA) can cause congestive cardiac failure, repeated pneumonia, pulmonary hypertension and an increased risk for endocarditis. Transcatheter closure of PDA is currently the preferred therapeutic alternative to...
Patent ductus arteriosus (PDA)...
08/01/2008
Journal of Invasive Cardiology